Idorsia competitorsClear all

Idorsia's top competitors include Novartis, Pfizer, Ipsen, Roche, Regeneron Pharmaceuticals, Vifor Pharma and Roivant Sciences.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Idorsia
Idorsia
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Ipsen
Ipsen
Ipsen SA is a France-based pharmaceutical company that produces a range of various types of drugs.
Roche
Roche
Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Vifor Pharma
Vifor Pharma
Vifor Pharma is a diversified group active throughout the healthcare market which, among other things, develops, manufactures, and markets pharmaceutical products.
Roivant Sciences
Roivant Sciences
Roivant Sciences is a tech-enabled healthcare company focused on completing the development of late-stage drug candidates with the potential to improve the lives of patients and their families.
Founding Date
Founding Date
2017
Founding Date
1996
Founding Date
1849
Founding Date
1929
Founding Date
1896
Founding Date
1988
Founding Date
1927
Founding Date
2014
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Allschwil, CH HQ
Shanghai, CN
Lörrach, DE
Chiyoda City, JP
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Bentley, AU
Melbourne, AU
Mulgrave, AU
Sydney, AU
see more
Locations
Boulogne-Billancourt, FR HQ
Glen Waverley, AU
Merelbeke, BE
Hoofddorp, NL
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
North Ryde, AU
Sydney, AU
Wien, AT
Baku, AZ
see more
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Uxbridge, GB
Bernards, US
Rensselaer, US
Sleepy Hollow, US
see more
Locations
Glattbrugg, CH HQ
Melbourne, AU
Wien, AT
Antwerpen, BE
København, DK
Paris, FR
see more
Locations
New York, US HQ
Basel, CH
Employees
Employees
8007% increase
Employees
105,7942% increase
Employees
78,50011% decrease
Employees
5,700
Employees
101,4654% increase
Employees
9,12313% increase
Employees
2,600
Employees
3321% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
303.4 b
Valuation ($)
8.2 b
Valuation ($)
N/A
Valuation ($)
65 b
Valuation ($)
N/A
Valuation ($)
7 b
Twitter followers
Twitter followers
1.3 k
Twitter followers
298.1 k
Twitter followers
30.2 k
Twitter followers
5.5 k
Twitter followers
239.4 k
Twitter followers
31.1 k
Twitter followers
N/A
Twitter followers
1.5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
13
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
13
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
9.8
Average likes per tweet (last 30 days)
38.5
Average likes per tweet (last 30 days)
14
Average likes per tweet (last 30 days)
34
Average likes per tweet (last 30 days)
10.1
Average likes per tweet (last 30 days)
14.1
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
53.85%
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
92.31%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
263778
Alexa Website Rank
102511
Alexa Website Rank
31796
Alexa Website Rank
352894
Alexa Website Rank
78229
Alexa Website Rank
139075
Alexa Website Rank
361228
Alexa Website Rank
252784
Employee Rating
Employee Rating
3.8
Employee Rating
4.2
Employee Rating
4.2
Employee Rating
4
Employee Rating
4.2
Employee Rating
4.1
Employee Rating
3
Employee Rating
3.4

Financial

Revenue (est.)
Revenue (est.)
CHF23.8m (FY, 2019)
Revenue (est.)
$48.7b (FY, 2020)
Revenue (est.)
$41.9b (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
CHF60.3b (FY, 2020)
Revenue (est.)
$8.5b (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$15.1b (FY, 2020)
Cost of goods
$8.7b (FY, 2020)
Cost of goods
N/A
Cost of goods
CHF16.2b (FY, 2020)
Cost of goods
$1.1b (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$33.5b (FY, 2020)
Gross profit
$33.2b (FY, 2020)
Gross profit
N/A
Gross profit
CHF44.2b (FY, 2020)
Gross profit
$7.4b (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
(CHF494.6m) (FY, 2019)
Net income
$8.1b (FY, 2020)
Net income
$9.7b (FY, 2020)
Net income
N/A
Net income
CHF15.1b (FY, 2020)
Net income
$3.5b (FY, 2020)
Net income
N/A
Net income
N/A

Operating

Manufacturing Sites
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
43 (FY, 2020)
Manufacturing Sites
N/A
Manufacturing Sites
23 (FY, 2019)
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
44 (Q4, 2020)
Phase III Trials Products
24 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
22 (Q4, 2020)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
27 (Jan, 2022)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Registration Phase Products
Registration Phase Products
N/A
Registration Phase Products
5 (Q4, 2020)
Registration Phase Products
9 (FY, 2020)
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
US FDA Breakthrough Therapy Designations
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
6 (FY, 2017)
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
4 (FY, 2020)
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 7.8b
Total funding raised
$ 8.9m
Total funding raised
N/A
Total funding raised
$ 1.9b
For sources of this data, please see the company profile

View company profiles

Novartis
HQ
Basel, CH
Employees
105,794↑ 2% increase

Novartis is a company that researches, develops, manufactures, and markets healthcare products.

View company
Pfizer
HQ
New York, US
Employees
78,500↓ 11% decrease

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.

View company
Ipsen
HQ
Boulogne-Billancourt, FR
Employees
5,700

Ipsen SA is a France-based pharmaceutical company that produces a range of various types of drugs.

View company
Roche
HQ
Basel, CH
Employees
101,465↑ 4% increase

Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics.

View company